Enoxaparin Sodium
6 Inquiries
9041-08-1
Any port of China
1Kgs/bag
2021-10-31
API,Intermediate
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Heparin sodium
Other Name:Heparin,sodium salt;Heparin sodium;Sodium acid heparin;Sodium heparin;Depo-Heparin;Hed-Heparin;Hepathrom;Sodium heparinate;Pularin;Liquemin;Liquaemin sodium;Alfa 87-81;Alfa 88-247;Alfa 87-120;Alfa 87-163;Alfa 87-198;Reviparin sodium;Dalteparin sodium;Parnaparin sodium;Tinzaparin sodium;Kabi 2165;Fragmin;LHN 1;Logiparin;Inno-Hep;Fragmin IV;Ardeparin sodium;WY 90493RD;Normiflo;RP 54563;Minolteparin sodium;RO 11;Bemiparin sodium;H 2149;Lioton 1000;OP 2000;Deligoparin sodium;Hepalean;Panheprin;Thromboliquine;Minihep;Lipo-Hepinette;Thrombo-Hepin;Heparin Fragment Kabi 2165;Unihep;Monoparin;Hepsal;Longheparin;Heprinar;Lipo-Hepin;Sodium parnaparin;Ivor;Zibor;Badyket;Nadroparine sodium;Clivarin 1750;Hepaflush;Hepagumin;Viatromb;Semuloparin sodium;Heparine Choay;Adomiparin sodium;M 118 sodium;RO 14;Sevuparin sodium;Necuparanib sodium;M 402 sodium salt;Clivarina;101921-26-0;102785-31-9;12656-11-0;913079-23-9
CAS No.:9041-08-1
EC Number:232-681-7
HScode:30019010
Categories:
Characteristics-
Appearance:
white crystalline (fine)
Water Solubility:soluble in water, dimethyl sulfoxide and ethanol.H2O: 50 mg/mL, clear, faintly yellow
Storage Conditions:2-8°C
Toxicity:LD50 oral in rat: > 779000iu/kg
Specific rotation:D25 +47° (c = 1.5 in water)
Hazard IdentificationClassification of the substance or mixture
Not classified.
GHS label elements, including precautionary statements
Pictogram(s) No symbol. Signal word No signal word
Hazard statement(s) none
Precautionary statement(s) Prevention none
Response none
Storage none
Disposal none
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Distributor
-
Main Products:
API,Intermediate
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
30
-
Total Annual Revenue:
Above $100 million
-
Total Employees:
201-300
About Echemi Pharmaceutical
Echemi’s philosophy is to seek for higher quality, to explore frontier area. The progress of human society, the extension of life expectancy, and the conquest of disease are all derived from the numerous businesses and individuals who have quietly dedicated themselves in the pharmaceutical industry. It’s the controlling of supply chain quality that ensures the efficacy. It’s the continuous exploration that promotes the development of the pharmaceutical industry and benefits more future generations. The pursuit of high quality requires all partners of Echemi Pharmaceutical to be screened, whether its certificate, qualification or scale. In the field of renewal, we will embrace all new changes and make more contributions to the development of pharmaceutical industry.

Advantage for Pharmaceutical
• Having been working in pharmaceutical field for more then 15 years, we have experienced regulatory team, quality control team, sourcing team, technical support team, and logistics team. And we are familiar with the regulatory requirements from different areas, can offer tailored service for our customers.
• We have hundreds of strategic partners for APIs, intermediates, and custom synthesis. All of our partners are ready to support our customers with documents, and be audited.
• We can offer custom synthesis for some new chemical structures and some materials which there are no reliable suppliers.

Product Category
We care for human and animal health and we are committed to creating a better social environment.
• Human API
• Intermediate
• Veterinary API
• Agrochemical
• Fine Chemical
• Custom Synthesis
-
-
Inquiry History6 Inquiries
Country Product Purchase Quantity Date Posted
France
Heparin Sodium CAS 9041-08-1 with Anticoagulant Drugs and Antiplatelet
20000 MT Aug 31, 2023
Switzerland
Heparin Sodium CAS 9041-08-1 with Anticoagulant Drugs and Antiplatelet
10000 MT Aug 27, 2023
India
Heparin sodium
250 KG Aug 23, 2024
India
Sodium Heparin Porcine Origin
1 KG Mar 2, 2026
Pakistan
Heparin
50 KG Sep 20, 2023
India
Heparin Sodium
2000 Feb 24, 2024 Post an enquiry for this product